| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cancer diagnosis, risk assessment and prediction of therapeutic response by means of DNA methylation markers
|
Fiegl, Heidi
|
|
2007
|
23 |
1-2 |
p. 89-96
|
article
|
| 2 |
DNA methylation in colorectal cancer - Impact on screening and therapy monitoring modalities?
|
Zitt, Marion
|
|
2007
|
23 |
1-2 |
p. 51-71
|
article
|
| 3 |
Epigenetic markers and response to chemotherapy in cancer
|
Strathdee, Gordon
|
|
2007
|
23 |
1-2 |
p. 43-49
|
article
|
| 4 |
Epigenetic markers for molecular detection of prostate cancer
|
Costa, Vera L.
|
|
2007
|
23 |
1-2 |
p. 31-41
|
article
|
| 5 |
Epigenetics - DNA-based mirror of our environment?
|
Cooney, Craig A.
|
|
2007
|
23 |
1-2 |
p. 121-137
|
article
|
| 6 |
Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer
|
Cui, Hengmi
|
|
2007
|
23 |
1-2 |
p. 105-112
|
article
|
| 7 |
5-methylcytosine - The fifth base of DNA: The fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer?
|
Widschwendter, Martin
|
|
2007
|
23 |
1-2 |
p. 1-3
|
article
|
| 8 |
MGMT methylation status: The advent of stratified therapy in glioblastoma?
|
Hau, Peter
|
|
2007
|
23 |
1-2 |
p. 97-104
|
article
|
| 9 |
Statistical methods for evaluating DNA methylation as a marker for early detection or prognosis
|
Alonzo, Todd A.
|
|
2007
|
23 |
1-2 |
p. 113-120
|
article
|
| 10 |
The role of DNA methylation in the development and progression of lung adenocarcinoma
|
Kerr, Keith M.
|
|
2007
|
23 |
1-2 |
p. 5-30
|
article
|
| 11 |
The role of RASSF1A methylation in cancer
|
Hesson, Luke B.
|
|
2007
|
23 |
1-2 |
p. 73-87
|
article
|
Journal description